{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:08:26Z","timestamp":1782036506167,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"am","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.transproceed.2024.01.016","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T20:15:41Z","timestamp":1707855341000},"page":"534-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Daprodustat for Post-Transplant Anemia in Renal Transplant Recipients"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-2481","authenticated-orcid":false,"given":"Yuichi","family":"Machida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.01.016_bib0001","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1600-6135.2003.00224.x","article-title":"Anemia: a continuing problem following kidney transplantation","volume":"3","author":"Mix","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000496140","article-title":"Posttransplantation anemia in kidney transplant recipients","volume":"142","author":"Gafter-Gvili","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0003","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: a European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105020","article-title":"Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: a network meta-analysis","volume":"159","author":"Zheng","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2020111638","article-title":"Roxadustat versus epoetin alfa for treating anemia in patients with chronic kidney disease on dialysis: results from the randomized phase 3 ROCKIES study","volume":"33","author":"Fishbane","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0006","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1053\/j.ajkd.2015.11.021","article-title":"A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial","volume":"67","author":"Brigandi","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0007","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0008","article-title":"Efficacy and safety of daprodustat for anemia therapy in chronic kidney disease patients: a systematic review and meta-analysis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0009","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamainternmed.2022.0605","article-title":"Efficacy and safety of daprodustat for treatment of anemia of chronic kidney disease in incident dialysis patients: a randomized clinical trial","volume":"182","author":"Singh","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000513103","article-title":"Daprodustat compared with epoetin beta pegol for anemia in japanese patients not on dialysis: a 52-week randomized open-label phase 3 trial","volume":"52","author":"Nangaku","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0011","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.16011219","article-title":"Efficacy and safety of daprodustat compared with darbepoetin alfa in japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial","volume":"15","author":"Akizawa","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0012","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/ndt\/gfac342","article-title":"Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials","volume":"38","author":"Singh","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0013","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/jcm11102722","article-title":"Efficacy of different doses of daprodustat for anemic non-dialysis patients with chronic kidney disease: a systematic review and network meta-analysis","volume":"11","author":"Fadlalmola","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0014","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.3390\/ijms24033037","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors and iron metabolism","volume":"24","author":"Ogawa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0015","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.transproceed.2021.10.022","article-title":"Experience with the use of a novel agent, hypoxia-inducible factor prolyl hydroxylase inhibitor, for posttransplant anemia in renal transplant recipients: a case report","volume":"54","author":"Naganuma","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0016","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.transproceed.2022.02.004","article-title":"Therapeutic effect of roxadustat on patients with posttransplant anemia","volume":"54","author":"Miki","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0017","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.21037\/apm-21-2916","article-title":"Efficacy and safety of roxadustat in the treatment of renal allograft anemia patients: a case series","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0018","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12882-021-02304-2","article-title":"Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis","volume":"22","author":"Ichii","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0019","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1210\/clinem\/dgad483","article-title":"Effect of roxadustat on thyroid function in patients with renal anemia","volume":"109","author":"Haraguchi","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0020","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.04641007","article-title":"Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection","volume":"3","author":"Chhabra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0021","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semnephrol.2018.02.006","article-title":"HIF activation against CVD in CKD: novel treatment opportunities","volume":"38","author":"Tanaka","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/nep.13835","article-title":"Recommendations by the Asian Pacific Society of Nephrology (APSN) on the appropriate use of HIF-PH inhibitors","volume":"26","author":"Yap","year":"2021","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.transproceed.2024.01.016_bib0023","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/01.ASN.0000126194.77004.9B","article-title":"Malignancy in renal transplantation","volume":"15","author":"Morath","year":"2004","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T03:52:54Z","timestamp":1714017174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0041134524000320"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.01.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daprodustat for Post-Transplant Anemia in Renal Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}